Correlation Between Ikena Oncology and Sana Biotechnology

Can any of the company-specific risk be diversified away by investing in both Ikena Oncology and Sana Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ikena Oncology and Sana Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Ikena Oncology and Sana Biotechnology, you can compare the effects of market volatilities on Ikena Oncology and Sana Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ikena Oncology with a short position of Sana Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ikena Oncology and Sana Biotechnology.

Diversification Opportunities for Ikena Oncology and Sana Biotechnology

-0.14

Correlation Coefficient

Ikena Oncology  Sana Biotechnology

Good diversification

The 3 months correlation between Ikena and Sana is -0.14. Overlapping area represents the amount of risk that can be diversified away by holding Ikena Oncology and Sana Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sana Biotechnology and Ikena Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ikena Oncology are associated (or correlated) with Sana Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sana Biotechnology has no effect on the direction of Ikena Oncology i.e., Ikena Oncology and Sana Biotechnology go up and down completely randomly.

Pair Corralation between Ikena Oncology and Sana Biotechnology

Given the investment horizon of 90 days Ikena Oncology is expected to under-perform the Sana Biotechnology. But the stock apears to be less risky and, when comparing its historical volatility, Ikena Oncology is 9.72 times less risky than Sana Biotechnology. The stock trades about -0.12 of its potential returns per unit of risk. The Sana Biotechnology is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  161.00  in Sana Biotechnology on December 28, 2024 and sell it today you would earn a total of  24.00  from holding Sana Biotechnology or generate 14.91% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Ikena Oncology  vs.  Sana Biotechnology

Ikena Oncology

Risk-Adjusted Performance

Very Weak

Over the last 90 days Ikena Oncology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Sana Biotechnology

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Sana Biotechnology are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Sana Biotechnology sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Ikena Oncology and Sana Biotechnology

The main advantage of trading using opposite Ikena Oncology and Sana Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ikena Oncology position performs unexpectedly, Sana Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sana Biotechnology will offset losses from the drop in Sana Biotechnology's long position.

The idea behind Ikena Oncology and Sana Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.